Skip to main content
SpringerLink
Log in

PET and PET/CT in Head and Neck Cancer

  • Chapter
PET/CT

  • 1285 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Cancer Society (www.cancer.org); 2005 Accessed March 2005.

    Google Scholar 

  2. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, sixth edition. New York: Springer-Verlag; 2002.

    Google Scholar 

  3. Bailet JW, Abemayor E, Jabour BA, et al. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102(3):281–288.

    Article  PubMed  CAS  Google Scholar 

  4. von Schulthess GK. Positron emission tomography versus positron emission tomography/computed tomography: from “unclear” to “new-clear” medicine. Mol Imaging Biol 2004;6(4):183–187.

    Article  Google Scholar 

  5. Cerfolio RJ, Ojha B, Bryant AS, et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78(3):1017–1023.

    Article  PubMed  Google Scholar 

  6. Rusthoven KE, Koshy M, Paulino AC. The role of PET-CT fusion in head and neck cancer. Oncology (Huntingt) 2005;19(2):241–246.

    Google Scholar 

  7. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29(9):1521–1525.

    PubMed  CAS  Google Scholar 

  8. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36(10):1747–1757.

    PubMed  CAS  Google Scholar 

  9. Wong WL, Chevretton EB, McGurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 1997;22(3):209–214.

    Article  PubMed  CAS  Google Scholar 

  10. Paulus P, Sambon A, Vivegnis D, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108(10):1578–1583.

    Article  PubMed  CAS  Google Scholar 

  11. Reisser C, Haberkorn U, Dimitrakopoulou-Strauss A, et al. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head Neck Surg 1995;121:272–276.

    PubMed  CAS  Google Scholar 

  12. Johansen J, Eigtved A, Buchwald C, et al. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002;112(11):2009–2014.

    Article  PubMed  Google Scholar 

  13. Jungehulsing M, Scheidhauer K, Damm M, et al. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000;123(3):294–301.

    Article  PubMed  CAS  Google Scholar 

  14. Leon X, Quer M, Diez S, et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21(3):204–210.

    Article  PubMed  CAS  Google Scholar 

  15. Kau RJ, Alexiou C, Laubenbacher C, et al. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999;125(12):1322–1328.

    PubMed  CAS  Google Scholar 

  16. Hannah A, Scott AM, Tochon-Danguy H, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002;236(2):208–217.

    Article  PubMed  Google Scholar 

  17. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36(10):1747–1757.

    PubMed  CAS  Google Scholar 

  18. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25(9):1255–1260.

    Article  PubMed  CAS  Google Scholar 

  19. Di Martino E, Nowak B, Hassan HA, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126(12):1457–1461.

    PubMed  Google Scholar 

  20. Nowak B, Di Martino E, Janicke S, et al. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999;38(8):312–318.

    PubMed  CAS  Google Scholar 

  21. Schmid DT, Stoeckli SJ, Bandhauer F, et al. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 2003;113(5):888–891.

    Article  PubMed  Google Scholar 

  22. Keyes JW, Jr., Chen MY, Watson NE Jr., et al. FDG PET evaluation of head and neck cancer: value of imaging the thorax. Head Neck 2000;22(2):105–110.

    Article  PubMed  Google Scholar 

  23. Wax MK, Myers LL, Gabalski EC, et al. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128(6):703–707.

    PubMed  Google Scholar 

  24. Kitagawa Y, Nishizawa S, Sano K, et al. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93(2):202–207.

    Article  PubMed  Google Scholar 

  25. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27(3):175–181.

    Article  PubMed  Google Scholar 

  26. Lonneux M, Lawson G, Ide C, et al. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000;110(9):1493–1497.

    Article  PubMed  CAS  Google Scholar 

  27. Velazquez RA, McGuff HS, Sycamore D, et al. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130(1):74–77.

    Article  PubMed  Google Scholar 

  28. Goerres GW, Schmid DT, Bandhauer F, et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130(1):105–109.

    Article  PubMed  Google Scholar 

  29. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 2002;197:205–211.

    Google Scholar 

  30. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109(6):970–975.

    Article  PubMed  CAS  Google Scholar 

  31. Fischbein NJ, AAssar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19(7):1189–1196.

    PubMed  CAS  Google Scholar 

  32. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004;233(1):93–100.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Boston University School of Medicine, Boston, MA, USA

    Nirav P. Shah MD (Director of PET/CT Imaging and Assistant Professor)

  2. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident)

  3. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor and Department of Radiology, Director of Nuclear Medicine)

Authors
  1. Nirav P. Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald B. Workman Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Edward Coleman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident) (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor Department of Radiology and Director of Nuclear Medicine) (Professor Department of Radiology and Director of Nuclear Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shah, N.P., Workman, R.B., Coleman, R.E. (2006). PET and PET/CT in Head and Neck Cancer. In: Workman, R.B., Coleman, R.E. (eds) PET/CT. Springer, New York, NY . https://doi.org/10.1007/978-0-387-38335-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38335-4_7

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32166-0

  • Online ISBN: 978-0-387-38335-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation